用户名: 密码: 验证码:
Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells
详细信息    查看全文
  • 作者:Yong Xia (1)
    Pham Ngoc Khoi (1)
    Hyun Joong Yoon (1)
    Sen Lian (1)
    Young Eun Joo (1)
    Kee Oh Chay (1)
    Kyung Keun Kim (1)
    Young Do Jung (1) (2)
  • 关键词:Piperine ; IL ; 6 ; Gastric cancer ; p38MAPK ; STAT3
  • 刊名:Molecular and Cellular Biochemistry
  • 出版年:2015
  • 出版时间:January 2015
  • 年:2015
  • 卷:398
  • 期:1-2
  • 页码:147-156
  • 全文大小:923 KB
  • 参考文献:1. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev 19:1893-907 CrossRef
    2. Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A (2014) Treatment of gastric cancer. World J Gastroenterol 20:1635-649 CrossRef
    3. Ohshima H, Tatemichi M, Sawa T (2003) Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417:3-1 CrossRef
    4. Cheng T-Y, Wu M-S, Hua K-T, Kuo M-L, Lin M-T (2014) Cyr61/CTGF/Nov family proteins in gastric carcinogenesis. World J Gastroenterol 20:1694-700 CrossRef
    5. Chung HW, Lim JB (2014) Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol 20:1667-680 CrossRef
    6. Lin MT, Lin BR, Chang CC, Chu CY, Su HJ, Chen ST, Jeng YM, Kuo ML (2007) IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Int J Cancer 120:2600-608 CrossRef
    7. Garbers C, Hermanns HM, Schaper F, Muller-Newen G, Grotzinger J, Rose-John S, Scheller J (2012) Plasticity and cross-talk of interleukin 6-type cytokines. Cytokine Growth Factor Rev 23:85-7 CrossRef
    8. Guo Y, Xu F, Lu T, Duan Z, Zhang Z (2012) Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 38:904-10 CrossRef
    9. Yin Y, Si X, Gao Y, Gao L, Wang J (2013) The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma. Oncol Rep 29:34-8
    10. Lee SA, Choi SR, Jang JS, Lee JH, Roh MH, Kim SO, Kim MC, Kim SJ, Jeong JS (2010) Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection. Dig Dis Sci 55:1955-963 CrossRef
    11. Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T, Aoki T, Ohnuma S (2005) Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer 8:124-31 CrossRef
    12. Wang Z, Si X, Xu A, Meng X, Gao S, Qi Y, Zhu L, Li T, Li W, Dong L (2013) Activation of STAT3 in human gastric cancer cells via interleukin (IL)-6-type cytokine signaling correlates with clinical implications. PLoS ONE 8:e75788 CrossRef
    13. Necula LG, Chivu-Economescu M, Stanciulescu EL, Bleotu C, Dima SO, Alexiu I, Dumitru A, Constantinescu G, Popescu I, Diaconu CC (2012) IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in Gp130 subunits. J Gastrointest Liver Dis 21:23-9
    14. Jackson CB, Judd LM, Menheniott TR, Kronborg I, Dow C, Yeomans ND, Boussioutas A, Robb L, Giraud AS (2007) Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression. J Pathol 213:140-51 CrossRef
    15. Apte RN, Dotan S, Elkabets M, White MR, Reich E, Carmi Y, Song X, Dvozkin T, Krelin Y, Voronov E (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev 25:387-08 CrossRef
    16. Cahill CM, Rogers JT (2008) Interleukin (IL) 1β induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IκB kinase α pathway targeting activator protein-1. J Biol Chem 283:25900-5912 Yong Xia (1)
    Pham Ngoc Khoi (1)
    Hyun Joong Yoon (1)
    Sen Lian (1)
    Young Eun Joo (1)
    Kee Oh Chay (1)
    Kyung Keun Kim (1)
    Young Do Jung (1) (2)

    1. Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju, 501-190, Republic of Korea
    2. Department of Biochemistry, Chonnam National University Medical School, 5 Hakdong, Gwangju, 501-190, Republic of Korea
  • ISSN:1573-4919
文摘
Piperine, a kind of natural alkaloid found in peppers, has been reported to exhibit anti-oxidative and anti-tumor activities, both in vitro and in vivo. Interleukin-6 (IL-6) is an important cytokine that activates the signal transduction, promotes tumor cell metastasis, and induces malignancy, including in gastric cancer. However, the effects of piperine on IL-6 expression in gastric cancer cells have not yet been well defined. In this study, we investigated the effects of piperine on the IL-6 expression, and examined the underlying signaling pathways via RT-PCR, promoter studies and Western blotting in human gastric cancer TMK-1 cells. Our results showed that piperine inhibited interleukin-1β (IL-1β)–induced IL-6 expression in a dose-dependent manner. In addition, piperine also inhibited IL-6 promoter activity. Experiments with mitogen-activated protein kinase (MAPK) inhibitors and dominant negative mutant p38 MAPK indicated that p38 MAPK was essential for IL-6 expression in the TMK-1 cells. Additionally, signal transducer and activator of transcription 3 (STAT3) was also involved in the IL-1β-induced IL-6 expression in gastric cancer cells. Piperine inhibited IL-1β-induced p38 MAPK and STAT3 activation and, in turn, blocked the IL-1β-induced IL-6 expression. Furthermore, gastric cancer cells pretreated with IL-1β showed markedly enhanced invasiveness, which was partially abrogated by treatment with IL-6 siRNA, piperine, and inhibitors of p38 MAPK and STAT3. These results suggest that piperine may exert at least part of its anti-cancer effect by controlling IL-6 expression through the suppression of p38 MAPK and STAT3.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700